Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Sales: 2013-2025

Historic Return on Sales for Agios Pharmaceuticals (AGIO) over the last 12 years, with Sep 2025 value amounting to -9.00%.

  • Agios Pharmaceuticals' Return on Sales fell 2941.00% to -9.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -9.00%, marking a year-over-year decrease of 2941.00%. This contributed to the annual value of 18.46% for FY2024, which is 3159.00% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Return on Sales of -9.00% as of Q3 2025, which was down 156.73% from 15.86% recorded in Q2 2025.
  • Agios Pharmaceuticals' Return on Sales' 5-year high stood at 20.42% during Q3 2024, with a 5-year trough of -26.42% in Q4 2022.
  • Its 3-year average for Return on Sales is -2.21%, with a median of -11.76% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 3,506bps in 2024, then tumbled by 2,941bps in 2025.
  • Agios Pharmaceuticals' Return on Sales (Quarterly) stood at -26.42% in 2022, then surged by 1,318bps to -13.24% in 2023, then surged by 3,161bps to 18.37% in 2024, then crashed by 2,941bps to -9.00% in 2025.
  • Its Return on Sales was -9.00% in Q3 2025, compared to 15.86% in Q2 2025 and 17.91% in Q1 2025.